Overall rank by patents
#2,132
of 49,997 tracked assignees
USPTO PatentsView assignee record - 185 granted patents across 55 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).
The verdict
According to USPTO PatentsView, Perkinelmer ranks #2,132 of 49,997 tracked US assignees by granted-patent volume, with 185 patents across 55 technology areas.
USPTO PatentsView assignee plate
Corpus R2132 · US Corporation #2,132 · 185 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: National Taiwan University of Science and Technology (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Sidel Participations S · near
57 score
Hefei Hualing · near
57 score
PerkinElmer Health… · this assignee
57 score
Sandvik Intellectual… · near
57 score
University Of Delaware · near
57 score
3D Lighting… · lowest
7 score
What this shows Perkinelmer's Innovation Score is 56.6/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, PerkinElmer Health Sciences, Inc. received 65 grants versus 120 in 2015–2019 (-46% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2016 at 28 grants and bottomed in 2024 at 1. Lead class G01N accounts for 44.9% of the portfolio across 55 subclasses. Volume neighbours: National Taiwan University of Science and Technology (#2,130) and Adtran, Inc. (#2,138).
From 2019–2021 to 2022–2024, PerkinElmer Health Sciences, Inc. moved from 71 to 19 grants (0.27x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,029. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
National Taiwan University of Science and Technology
185 patents
Ossur Iceland EHF
185 patents
PETRÓLEO Brasileiro S.A.—PETROBRAS
185 patents
Proterial, Ltd.
185 patents
Raytheon BBN Technologies Corp.
185 patents
ZEDEL
185 patents
PerkinElmer Health Sciences, Inc.
185 patents
Asics Corporation
184 patents
Adtran, Inc.
184 patents
What this shows PerkinElmer holds 185 patents at rank #2,134, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,134 in granted patent volume.
Other assignees with the most granted patents in PerkinElmer's primary technology class.
Two PlainPatent-derived peer sets for PerkinElmer, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (57 here).
Nearest assignees by average claims per patent (19.7 here).
Perkinelmer's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
57 Top 6% higher than 94% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 21 | 11.4% |
| 2016 | 28 | 15.1% |
| 2017 | 28 | 15.1% |
| 2018 | 18 | 9.7% |
| 2019 | 25 | 13.5% |
| 2020 | 22 | 11.9% |
| 2021 | 24 | 13.0% |
| 2022 | 13 | 7.0% |
| 2023 | 5 | 2.7% |
| 2024 | 1 | 0.5% |
Top 15 of 55 technology areas
Overall rank by patents
#2,132
of 49,997 tracked assignees
56.6 out of 100
What to do with this data
PerkinElmer Health Sciences, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.